Recommendations for the care of patients with heart failure and COVID-19

José A Cigarroa-López1,2,3, José A Magaña-Serrano1,2,3, Amada Álvarez-Sangabriel2,4

  • 1Asociación Nacional de Cardiólogos de México.

Insights

Patients with heart failure (HF) and transplant recipients are at high risk for severe COVID-19 complications. These recommendations guide medical personnel in caring for these vulnerable cardiovascular patients during the pandemic.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic presents significant global health and economic challenges.
  • Cardiovascular conditions, particularly heart failure (HF), place patients at higher risk for severe COVID-19 outcomes.
  • Immunosuppressed transplant recipients are also highly susceptible to severe infections.

Purpose of the Study:

  • To provide recommendations for the medical care of vulnerable cardiovascular patients during the COVID-19 pandemic.
  • To address the specific risks faced by patients with heart failure, heart transplants, and pulmonary arterial hypertension.
  • To guide healthcare professionals in managing these patients in various clinical settings, regardless of COVID-19 status.

Main Methods:

  • Development of clinical recommendations by the National Association of Cardiologists of Mexico (ANCAM) and the Mexican Society of Cardiology (SMC).
  • Consensus-based guidelines drawing on expertise in cardiology and infectious disease management.
  • Focus on high-risk patient groups including those with heart failure, ventricular assist devices, heart transplants, and pulmonary arterial hypertension.

Main Results:

  • Heart failure is a frequent complication of COVID-19, increasing severity.
  • Patients with advanced HF and transplant recipients on immunosuppressants face heightened risks.
  • Cardiological symptoms are observed in some COVID-19 patients, indicating complex interactions.

Conclusions:

  • Specific guidance is crucial for managing vulnerable cardiovascular patients during the COVID-19 pandemic.
  • Proactive care strategies are needed to mitigate risks in heart failure and transplant populations.
  • Collaboration between cardiology societies ensures comprehensive recommendations for patient care.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
168
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
149
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
333
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
218
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
214
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
236